ASCO 2018: Merck’s Keytruda on top in first-line NSCLC

The much-anticipated latest installment of the first-line non-small cell lung cancer (NSCLC) battle took place at this year’s American Society … Continue reading ASCO 2018: Merck’s Keytruda on top in first-line NSCLC